Cantor Fitzgerald Starts Cidara Therapeutics (CDTX) at Buy

October 28, 2016 8:06 AM EDT
Get Alerts CDTX Hot Sheet
Price: $9.25 +1.09%

Rating Summary:
    7 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade CDTX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Cantor Fitzgerald initiated coverage on Cidara Therapeutics (NASDAQ: CDTX) with a Buy rating and a price target of $20.

For an analyst ratings summary and ratings history on Cidara Therapeutics click here. For more ratings news on Cidara Therapeutics click here.

Shares of Cidara Therapeutics closed at $9.87 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Cantor Fitzgerald

Add Your Comment